PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Nomogram”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,243 records · Page 69Linked to original sources

Two late response components in on-off ganglion cells of the frog retina: the delayed response-generated by red rods; the second off-response-generated by green rods.

Frog on-off retinal ganglion cells react to diffuse, large-sized stimuli not only with an "early response" and a "delayed response" but also with a "second off-response". The intensity at which the delayed response becomes visible coincides with the quantum amount necessary for saturating the red rod response. The spectral sensitivity of the delayed response fits the nomogram for the 502 nm pigment. Unlike the delayed response, the second off-response appears earlier with increasing stimulus intensity and follows the 433 nm nomogram. Therefore, it is most probably generated by the green rods.

Animals↗

The spectral sensitivity of blue-sensitive pigeon cones: evidence for complete screening of the visual pigment by the oil-droplets.

The relative spectral sensitivity of blue-sensitive pigeon cones was determined using flicker-photometry based on mass ERG-responses from intact subjects during high-level light adaptation. The resulting spectral sensitivity curve can be mimicked by a P460 nomogram screened by an oil-droplet that absorbs 50% at 466 nm. Comparison of the curve with the nomogram indicates that on the average less than 10% of the light that excites the blue-sensitive cones is guided past or diffracted around their oil-droplets.

Adaptation, Ocular↗

Optimization of carrier frequency and duty cycle for pulse modulation of biological signals.

Digital modulation techniques are commonly used for the recording and transmission of biological signals. Hitherto, the choice of subcarrier frequency for recording or transmission of biological signals has been arbitary and this usually results in poor signal to noise ratio (SNR) due to the limited frequency characteristics of the system. In the present study the frequency characteristics of the system (first order approximation) has been taken to be that of a Butterworth filter. Computations based on this assumption show that for a given input signal there exists an optimum subcarrier frequency and a corresponding optimum duty cycle which would give maximum SNR of the system. For convenience, a nomogram has been prepared and it has been shown that for a given frequency response of the system, the nomogram could be used for selecting an optimum subcarrier frequency and a corresponding duty cycle. The theoretical formulations have been verified with experimental work.

Biomedical Engineering↗

X-ray controlled implantation of the brain stem.

Using X-rays to improve accuracy of stereotaxic implantation of the brain stem of Macaca irus monkeys overcomes the problems of moveable brain stem and inaccurate fixation in the stereotaxic frame. The method is independent of standard atlases and correct ear bar fixation. The key to the method is the establishment of a nomogram which relates the implantation target to bony landmarks. The nomogram is established by X-ray contrast studies which outline the brain stem, the implantation target in the brain stem being decided by superimposed histology. This target is nomographically related to bony landmarks seen both on the contrast X-ray and on a plain X-ray taken later at implantation with the monkey in the stereotaxic frame. Being able to locate the target on this plain X-ray, and having included on the X-ray a metal marker, the stereotaxic coordinates of which are known, the distance can be measured (allowing for X-ray magnification) between target and stereotaxic marker and thus one computes the target coordinates. Accuracy of implantation according to these coordinates is monitored with further plain X-rays.

Animals↗

Gender-specific reference M-mode values in adults: population-derived values with consideration of the impact of height.

OBJECTIVES: The purpose of this investigation was to derive population-based reference values for M-mode echocardiographic dimensions that can be applied in epidemiologic studies, clinical trials and clinical practice and to determine optimal methods for adjusting these dimensions for body size. BACKGROUND: M-mode echocardiography remains an important modality for studying cardiovascular disease; this is especially true with regard to detecting target organ damage in systemic hypertension. Most previously published reference values were derived from hospital-based series or relatively small samples and were not gender specific. METHODS: Using a sample of 288 men and 524 women who were between 20 and 45 years of age and who were free of cardiovascular disease, reference values were derived for end-diastolic and end-systolic left ventricular internal dimensions, left ventricular wall thickness and left atrial dimension. The relations between these dimensions and height, a measure of body size relatively independent of obesity, were investigated using various regression models. RESULTS: Nomograms for mean and 95th percentile values in men and women were constructed on the basis of linear regression models relating echocardiographic dimensions to height. Adjustment for body surface area greatly attenuated associations between obesity and cardiac dimensions in a separate healthy but less restricted sample of 411 men and 503 women. CONCLUSIONS: Gender-specific M-mode reference values and nomograms, with mean and 95th percentile values for echocardiographic dimensions as a function of height, are reported. The use of body surface area as means of body size adjustment is called into question.

Adult↗

Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts.

BACKGROUND: Increasing number of patients undergo percutaneous intervention of saphenous vein grafts (SVGs). However, the clinical factors associated with long-term mortality after SVG interventions are currently less known. Accordingly, the goal of present study was to evaluate clinical correlates of long-term mortality and to develop a simple bedside tool for risk stratification in patients undergoing SVG interventions. METHODS: We analyzed 1019 patients undergoing SVG interventions from the Duke Cardiovascular Disease Database (1986-2003). Cox proportional hazards model was used to identify baseline variables associated with long-term mortality, and the model variables were then used to construct a nomogram for survival probability at 4 years. RESULTS: At a median follow-up of 4 years, 24% of those undergoing SVG interventions died (interquartile range 2-7 years). Independent correlates of death at follow-up on multivariable analysis included presenting heart rate (hazard ratio [HR] 1.02, 95% CI 1.01-1.03), diabetes (HR 1.73, 95% CI 1.37-2.18), presenting heart failure (HR 1.62, 95% CI 1.27-2.06), age (per 10-year increase, HR 1.29, 95% CI 1.13-1.46), peripheral vascular disease (HR 1.59, 95% CI 1.23-2.04), renal insufficiency (HR 2.01, 95% CI 1.36-2.97), patent internal mammary graft (HR 0.67, 95% CI 0.53-0.86), body mass index < or = 25 kg/m2 (HR 0.91, 95% CI 0.85-0.97), carotid bruit (HR 1.44, 95% CI 1.12-1.85), S3 ventricular gallop (HR 1.83, 95% CI 1.11-3.03), and hypertension (HR 1.38, 95% CI 1.04-1.83) (c-index 0.83). Bootstrap validation confirmed excellent internal validity of the model (mean c-index 0.84, 95% CI 0.80-0.85). CONCLUSION: Long-term survival after SVG intervention is poor, with one fourth of patients dying at median follow-up of 4 years. The nomogram developed using the model variables provides a method for clinicians to advise patients undergoing SVG interventions regarding their long-term prognosis, thereby enhancing discharge and long-term follow-up planning and setting up of realistic expectations.

Aged↗

Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolism.

There remains considerable controversy regarding optimal initial warfarin dosing in patients with acute venous thromboembolism. Therefore, an open-label, randomized trial comparing 2 warfarin initiation nomograms (5 vs 10 mg) was conducted in patients with acute venous thromboembolism. All participants received fondaparinux for > or = 5 days as a "bridge" to warfarin. The primary end point was defined as the number of days necessary to achieve 2 consecutive international normalized ratio laboratory test values > 1.9. A total of 50 patients were enrolled and randomly assigned to each of the treatment arms. The median time to 2 consecutive international normalized ratios was 5 days in the 2 groups. There was no statistical difference in achieving the primary end point using either the 5- or the 10-mg nomogram (p = 0.69). These results should provide clinicians with increased warfarin dosing options in patients presenting with acute venous thromboembolism.

Acute Disease↗

Identification and external validation of a prognostic signature based on myeloid-derived suppressor cells-related LncRNAs to evaluate survival prognosis and treatment efficacy in invasive breast carcinoma.

BACKGROUND: Originating in the hematopoietic tissue, myeloid-derived suppressor cells (MDSCs) significantly contribute to tumor-related immunological processes. However, their relationship with long noncoding RNAs (lncRNAs) and breast cancer remains incompletely understood. In this study, we introduced MDSCs-associated lncRNAs as novel prognostic biomarkers to assess outcomes in patients with invasive breast carcinoma (BRCA). METHODS: Information regarding BRCA cases, including clinical and genomic details, was obtained from the TCGA repository. Predictive indicators were discovered, and their reliability underwent thorough verification. A clinically useful nomogram was developed following application-based validation. Additional investigations encompassed functional analysis, TMB assessment, TME profiling, immunotherapy efficacy forecasting, and drug sensitivity testing along with target identification. Long non-coding RNA expression was measured using reverse transcription quantitative PCR. RESULTS: A risk stratification model incorporating eight MDSCs-related lncRNAs effectively predicted patient outcomes. Kaplan-Meier (K-M) survival analysis clearly indicated a much worse prognosis among patients classified as high-risk (p&#xa0;<&#xa0;0.001). The nomogram accurately forecasted overall survival (OS). Analysis of functional enrichment revealed that pathways associated with epithelial cells showed activity among patients at higher risk. Characterization of the tumor microenvironment showed increased immune cell presence in those classified as low-risk. Conversely, individuals with greater risk displayed higher tumor mutational burden. TIDE and IPS analyses indicated superior immunotherapy responsiveness in the low-risk BRCA subgroup. Among 47 drugs with notable IC50 variations, Ribociclib, PD173074, KU-55933, NU7441, and nutlin-3a exhibited lower IC50 values within the low-risk group, whereas Lapatinib demonstrated greater efficacy among the high-risk group. Moreover, 10 potential therapeutic agents and their targets were predicted for high-risk patients. RT-qPCR validation confirmed the robustness of the model. CONCLUSIONS: We successfully verified a new model of molecular markers of MDSCs-related lncRNAs, offering critical insights for predicting outcomes and guiding therapeutic decisions in BRCA cases.

Bioinformatics↗

Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen, and Gleason score to predict prostate cancer recurrence after radical prostatectomy.

OBJECTIVE: An artificial neural network analysis (ANNA) was developed to predict the biochemical recurrence more effectively than regression models based on the combined use of pelvic coil magnetic resonance imaging (pMRI), prostate specific antigen (PSA) and biopsy Gleason score in patients with clinically organ-confined prostate cancer after radical prostatectomy (RP). METHODS: Two-hundred-and-ten patients undergoing retropubic RP with pelvic lymphadenectomy were evaluated. Predictive study variables included clinical TNM classification, preoperative serum PSA, biopsy Gleason score, transrectal ultrasound (TRUS) findings, and pMRI findings. The predicted result was a biochemical failure (PSA >or=0.1 ng/ml). Using a five-way cross-validation method, the predicted ability of ANNA for a validation set of 200 randomly selected patients was compared with those of Cox regression analysis and "Kattan nomogram" by area under the receiver operating characteristic curve (AUC) analysis. RESULTS: Seventy-three patients (35%) failed at median follow-up of 61 (mean: 60, range: 2-94) months. Using similar input variables, the AUC of ANNA (0.765, 95% Confidence Interval [CI]: 0.704-0.825) was comparable (p > 0.05) to those for Cox regression (0.738, 95%CI: 0.691-0.819) and Kattan nomogram (0.728, 95%CI: 0.644-0.819). Contrarily, adding the pMRI findings, the ANNA is significantly (p < 0.05) superior to any other predictive model (0.897, 95%CI: 0.841-0.977). The Gleason score represented the most influential predictor (relative weight: 2.4) of PSA recurrence, followed by pMRI (2.2), and PSA (2.0). CONCLUSION: ANNA is superior to regression models to predict accurately biochemical recurrence. The relative importance of pMRI and the utility of ANNA to predict the PSA failure in patients referred for RP must be confirmed in further trials.

Biomarkers, Tumor↗

The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.

INTRODUCTION: We examined the prognostic value of AJCC pT2 substages in prediction of biochemical recurrence (BCR) after radical prostatectomy (RP), in European patients. METHODS: A cohort of 1726 RP patients with pT2N0 prostate cancer (PCa) was studied. Multivariate Cox regression models addressed the association between either the 1997 or 1992/2002 pT2 substages after controlling for total PSA, primary and secondary pathologic Gleason scores and surgical margin status and time to PSA recurrence (PSA >0.1 and rising) after RP. Regression coefficients were then used to test the predictive accuracy of multivariate models in a nomogram setting. RESULTS: PSA recurrence occurred in 80 (4.6%) patients. Mean and median times to recurrence were respectively 28.9 and 24.4 months. In univariate analyses, neither the 1997 (p = 0.48) nor the 1992/2002 pT2 substages (p = 0.054) were predictive of recurrence. In multivariate analyses the lack of significance persisted (1997 p = 0.709; 1992/2002 p = 0.124). When either the 1997 or 1992/2002 pT2 substages were added to a multivariate nomogram without pT2 substage information, its accuracy respectively decreased by 0.8% and 1.1%. CONCLUSION: Our data indicate that pT2 substages offer no incremental value relative to pre-treatment total PSA, surgical margin status and pathologic Gleason scores. Therefore, it might be postulated that it is sufficient to confirm organ confinement according to Partin's pathologic staging.

Analysis of Variance↗

Nomographic representation of logistic regression models: a case study using patient self-assessment data.

Logistic regression models are widely used in medicine, but difficult to apply without the aid of electronic devices. In this paper, we present a novel approach to represent logistic regression models as nomograms that can be evaluated by simple line drawings. As a case study, we show how data obtained from a questionnaire-based patient self-assessment study on the risks of developing melanoma can be used to first identify a subset of significant covariates, build a logistic regression model, and finally transform the model to a graphical format. The advantage of the nomogram is that it can easily be mass-produced, distributed and evaluated, while providing the same information as the logistic regression model it represents.

Algorithms↗

Does dilated wavefront aberration measurement provide better postoperative outcome after custom LASIK?

PURPOSE: To compare outcomes after custom LASIK based on non-pharmacologically dilated (natural mesopic pupil) and pharmacologically dilated wavefront aberration measurement. DESIGN: Case-control study. PARTICIPANTS AND CONTROLS: The study group included 81 myopic eyes from 81 patients (mean preoperative spherical equivalent [SE], -4.15+/-1.97 diopters [D]). The control group consisted of 87 myopic eyes from 87 patients (mean preoperative SE, -4.98+/-2.00 D). METHODS: The 81-eye study cohort was treated based on nonpharmacological low mesopic dilated wavefront aberration measurement (Zywave aberrometer), and the postoperative outcome was compared with that of the control group of 87 eyes treated, based on pharmacologically dilated (2.5% neosynephrine) wavefront data, using the Zyoptix platform. The same nomogram was used for both groups, which adjusts sphere based on the amount of preoperative higher-order aberration. All eyes had a low mesopic pupil diameter of > or =6.3 mm without pharmaceutical intervention. MAIN OUTCOME MEASURE: Postoperative 3-month visual acuity (VA), contrast sensitivity, and refractive error. RESULTS: Of the non-pharmacologically dilated eyes (study) and pharmacologically dilated (control) eyes, 96.3% and 96.6%, respectively, attained postoperative uncorrected VA of 20/20 or better. Although 96.6% of the eyes were within the target SE of +/-0.50 D in the control group, 100% of the 81 study eyes were within an SE of +/-0.50 D postoperatively. The range of postoperative SE (-0.75 to +1 D) was slightly reduced among the study eyes (+/-0.50 D). Differences were not statistically significant. CONCLUSIONS: When a low mesopic pupil dilates to > or =6.3 mm, pharmacological dilation with wavefront-guided ablation may provide no additional benefit with regard to spherical accuracy when compared with nonpharmacological wavefront-guided ablation. The use of the Rochester nomogram, which accounts for aberration interaction, provided excellent results with or without pharmacological dilation.

Case-Control Studies↗

A case series of hospitalized patients with elevated digoxin levels.

PURPOSE: Although there is renewed enthusiasm for the use of digoxin in patients with heart failure, current dosing guidelines are based on a nomogram published in 1974. We studied the incidence of and risk factors for elevated digoxin levels in patients admitted to a community hospital, and compared their dosage regimens to published guidelines. SUBJECTS AND METHODS: We reviewed the charts of all patients who had serum digoxin levels greater than 2.4 ng/mL during a 6-month period. We collected demographic and clinical data, indications for digoxin use, digoxin dosage, concurrent medications, laboratory data, and clinical and electrocardiographic features of digoxin toxicity. RESULTS: Of the 1,433 patients with digoxin assays, 115 (8%) patients had elevated levels. Of the 82 patients with complete records and correctly timed digoxin levels, 59 (72%) had electrocardiographic or clinical features of digoxin toxicity. Patients with serum digoxin levels >2.4 ng/mL were slightly older (78 +/- 8 versus 73 +/- 9 years of age; P = 0.12) and had greater serum creatinine levels (3.1 +/- 7.3 versus 1.4 +/- 0.3 mg/dL; P = 0.01) than those with levels < or =2.4 ng/mL. Forty-seven patients had elevated digoxin levels on admission, including 21 patients admitted for digoxin toxicity. Impaired or worsening renal function contributed to high levels in 37 patients, and a drug interaction was a contributory factor in 10 cases. Twenty (43%) of these patients were taking the recommended maintenance dose based on the scheme employed in the Digitalis Investigation Group study. Thirty-five patients developed high digoxin levels while in hospital. In 26 patients, this followed a loading dose of digoxin for the control of rapid atrial fibrillation. Impaired renal function was implicated in all of these patients. Despite the elevated digoxin level, rate control was achieved in only 11 patients of these patients. CONCLUSIONS: Elevated digoxin levels and clinical toxicity remains a common adverse drug reaction. Elderly patients, particularly those with impaired renal function and low body weights, are at the greatest risk. As published digoxin nomograms often result in toxicity, clinical variables need to be monitored. In patients with congestive heart failure and normal sinus rhythm the potential benefit of digoxin is small; thus, patients should receive a dose that minimizes the risk of toxicity. For patients with new onset atrial fibrillation, other agents may be preferable for rate control.

Age Factors↗

Transverse cerebellar diameter measurements in twin pregnancies and the effect of intrauterine growth retardation.

OBJECTIVES: Transverse cerebellar diameter measurements have been established for singleton but not twin pregnancies. In singleton pregnancies controversy exists on whether cerebellar growth is affected by intrauterine growth retardation. We undertook this retrospective study in twin pregnancies to establish a nomogram for the transverse cerebellar diameter in twins and to assess the effect of growth retardation on this measurement. STUDY DESIGN: A retrospective review was performed on 171 patients with twin pregnancies with reliable dating from 15 to 36 weeks' gestation who had been referred to our antenatal evaluation unit for routine ultrasonographic examination. Of the 342 fetuses, 322 were available for analysis and establishment of a nomogram for the transverse cerebellar diameter. Twenty-four twin, growth-retarded fetuses were analyzed separately. RESULTS: The transverse cerebellar diameter increased linearly with gestational age (r = 0.94, p < 0.001). Fifteen (63%) of the growth-retarded fetuses had a transverse cerebellar diameter of < or = 5th percentile for gestational age. CONCLUSION: We suggest that intrauterine growth retardation may affect cerebellar growth in twins.

Cerebellum↗

Effect of astigmatic keratotomy on spherical equivalent: results of the Astigmatism Reduction Clinical Trial.

PURPOSE: To determine the effect of astigmatic keratotomy on spherical equivalent, as measured by the coupling ratio and a new quantity, coupling constant. METHODS: In a prospective multicenter study, subjects underwent arcuate keratotomy at a 7-mm optical zone by means of the Lindstrom nomogram for correction of astigmatism. One hundred fifty-seven eyes of 95 patients who had a follow-up examination 1 month postoperatively were studied. Mean preoperative refractive cylinder +/- SEM was 2.82 +/- 1.17 diopters. Coupling ratio was defined as the ratio of the flattening of the incised meridian to the steepening of the opposite meridian. Coupling constant was defined as the ratio of the change in spherical equivalent to the magnitude of the vector change in astigmatism. Coupling ratio, coupling constant, and change in spherical equivalent were calculated on the basis of change in refraction and keratometry. RESULTS: On the basis of change in refraction, coupling ratio was 0.95 +/- 0.10 (mean +/- SEM) and coupling constant was -0.01 +/- 0.03, consistent with a minor shift in the spherical equivalent of -0.03 +/- 0.07 diopter. On the basis of change in keratometry, coupling ratio was 0.84 +/- 0.05 and coupling constant was -0.04 +/- 0.02, consistent with minor postoperative keratometric steepening of -0.10 +/- 0.04 diopter. Coupling ratio based on change in refraction was not statistically different from the coupling ratio predicted by the Gauss' law for inelastic domes (P = .370). Incision length and number, amount of achieved cylinder correction, age, and sex had no statistically significant effect on coupling ratio, coupling constant, and change in spherical equivalent. CONCLUSIONS: Cornea behaved as an inelastic surface in response to arcuate keratotomy performed with the Astigmatism Reduction Clinical Trial study nomogram. On average, astigmatic keratotomy had a minimal effect on spherical equivalent refraction. There was variability, however, in coupling ratio, coupling constant, and change in spherical equivalent from eye to eye after astigmatic keratotomy. Caution is therefore advised when simultaneous correction of cylinder and spherical equivalent is planned.

Adolescent↗

Xanthine oxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis.

OBJECTIVE: To investigate the expression of xanthine oxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. DESIGN: Immunohistochemical identification of xanthine oxidase in endometrial tissues by using polyclonal antibody. SETTING: University hospital. PATIENT(S): Thirty-four women with endometriosis, 34 women with adenomyosis, and 44 fertile control women. INTERVENTION(S): Biopsy samples were obtained from the endometrium throughout the menstrual cycle. MAIN OUTCOME MEASURE(S): Semiquantitative immunostaining (evaluation nomogram) score of endometrial cells. RESULT(S): The level of xanthine oxidase expression in the glandular epithelium of control varied according to menstrual phase, but no such variation in expression was seen in endometriosis. Variation in xanthine oxidase expression was observed during the menstrual cycle in patients with adenomyosis; this variation differed completely from that in controls. Xanthine oxidase expression was found in ectopic endometrial tissue in all cases. The mean evaluation nomogram levels in the glandular epithelium in adenomyosis tissue were as high as those in the early secretory phase in the eutopic endometrium. CONCLUSION(S): Aberrant expression of xanthine oxidase in eutopic and ectopic endometrium appears to play a pathologic role in endometriosis and adenomyosis.

Anemia, Iron-Deficiency↗

The effect of altitude on radial keratotomy.

The authors analyzed refractive results of patients who underwent radial keratotomy (RK) at sea level and high altitude and evaluated the effects of the altitude. A total of 102 eyes undergoing RK procedures performed in two clinical centers having different altitude were analyzed. The results compared between subjects who had undergone RK at sea level (Istanbul/Turkey) and at an altitude of 5750 feet (Van/Turkey) were compared. Subjects were 19-42 years old with myopia from -4.00 to -12.00 diopters (D). The average preoperative spherical equivalent cycloplegic refractions (SECR) were -8.01 +/- 1.86 D and -6.99 +/- 2.15 D in the Istanbul and Van groups, respectively. These were divided into subgroups according to myopia degree and number of incisions and optic zone size. The RK procedures were performed by the same surgeon with diamond blade in standard Russian style. The average changes in SECR were 5.09 +/- 1.29 D and 6.50 +/- 2.24 D in subjects who had undergone RK at sea level and at 5750 feet, respectively. There was a significant difference between the subgroups (P < 0.0002). This difference was especially higher in the high myopia subgroups. Additionally, we obtained a partial relation between increase of RK incision number and SECR change at high altitude but not at sea level. No notable regression and progression were seen in the 3 months of follow-up at high altitude. These results support hypotheses suggesting both corneal hypoxic expansion in the area of RK incisions, which may lead to central corneal flattening, and barometric pressure directly altering corneal shape, which is responsible for the hyperopic shift induced by altitude. Ophthalmologists performing RK surgery at high altitude had better consider redesigning their RK nomograms in light of these findings. However, when the nomogram used at sea level was used at high altitude, the subjects became hyperopic.

Adult↗

Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults.

Estimates of body surface area were made based on measurement of 81 subjects, ranging from premature infants to adults. SA was calculated geometrically for each subject from 34 body measurements, and the values obtained compared with those based on previously published formulas and graphs. The most widely used formula, that of Du Bois and Du Bois, increasingly underestimated SA as values fell below 0.7 m2; the disparity was greatest in the newborn infant (7.96%). Closer agreement was obtained with the equations and nomograms of Body, Brody, Faber and Melcher, and Sendroy and Cecchini, although minor deviations were noted in some age ranges. The formula SA (m2) = weight (kg)0.5378 X height (cm)0.3964 X 0.024265, derived from the measured data by multiple regression analysis, gave a good fit for all values of SA from less than 0.2 m2 to greater than 2.0 m2 (r = 0.998). This formula was used to construct nomograms for estimation of SA in infants, children, and adults from height (length) and weight.

Adult↗